Tomasz (Tom) Beer

Professor

  • 15774 Citations
  • 56 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2017

Management of anticoagulation in patients with prostate cancer receiving enzalutamide

Shatzel, J. J., Daughety, M. M., Olson, S. R., Beer, T. T. & Deloughery, T., Nov 1 2017, In : Journal of Oncology Practice. 13, 11, p. 720-727 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
2016

Raising the bar for therapeutic trials in advanced prostate cancer

Alumkal, J. & Beer, T. T., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 2958-2960 3 p.

Research output: Contribution to journalReview article

2 Scopus citations

Treatment of Nonmetastatic Castration-Resistant Prostate Cancer

Luo, J., Beer, T. M. & Graff, J. N., Apr 1 2016, In : Oncology (Williston Park, N.Y.). 30, 4, p. 336-344 9 p.

Research output: Contribution to journalReview article

6 Scopus citations
2015

Bevicizumab and thrombosis: Some answers but questions remain

Deloughery, T. G. & Beer, T. M., Apr 1 2015, In : Cancer. 121, 7, p. 975-977 3 p.

Research output: Contribution to journalReview article

1 Scopus citations

Reducing skeletal-related events in metastatic castration-resistant prostate cancer

Graff, J. N. & Beer, T. M., Jun 15 2015, In : ONCOLOGY (United States). 29, 6

Research output: Contribution to journalReview article

6 Scopus citations

Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer

Graff, J. N., Gordon, M. J. & Beer, T. M., Apr 1 2015, In : Expert Opinion on Pharmacotherapy. 16, 5, p. 749-754 6 p.

Research output: Contribution to journalReview article

6 Scopus citations
2014

Personalizing prostate cancer therapy: The way forward

Cetnar, J. P. & Beer, T. M., Sep 2014, In : Drug Discovery Today. 19, 9, p. 1483-1487 5 p.

Research output: Contribution to journalReview article

8 Scopus citations
11 Scopus citations

Sequencing therapy in advanced prostate cancer: Focus on sipuleucel-T

Quinn, D. I., Vaishampayan, U., Higano, C. S., Lin, D. W., Shore, N. D. & Beer, T. M., Jan 2014, In : Expert review of anticancer therapy. 14, 1, p. 51-61 11 p.

Research output: Contribution to journalReview article

4 Scopus citations
2013
1 Scopus citations

The role of C-reactive protein in prostate cancer

Graff, J. N. & Beer, T. M., Sep 15 2013, In : Cancer. 119, 18, p. 3262-3264 3 p.

Research output: Contribution to journalReview article

4 Scopus citations
2011

New therapies for castration-resistant prostate cancer: Efficacy and safety

Beltran, H., Beer, T. M., Carducci, M. A., De Bono, J., Gleave, M., Hussain, M., Kelly, W. K., Saad, F., Sternberg, C., Tagawa, S. T. & Tannock, I. F., Aug 1 2011, In : European Urology. 60, 2, p. 279-290 12 p.

Research output: Contribution to journalReview article

107 Scopus citations

Prostate cancer and vitamin D: What does the evidence really suggest?

Barnett, C. M. & Beer, T. M., Aug 1 2011, In : Urologic Clinics of North America. 38, 3, p. 333-342 10 p.

Research output: Contribution to journalReview article

8 Scopus citations

Toward predictors of survival in castration-resistant prostate cancer

Graff, J. N. & Beer, T. M., Sep 1 2011, In : Cancer. 117, 17, p. 3882-3884 3 p.

Research output: Contribution to journalReview article

2 Scopus citations
2009

Optimal timing of chemotherapy in androgen independent prostate cancer

Schnadig, I. D. & Beer, T. M., Jan 1 2009, In : Urologic Oncology: Seminars and Original Investigations. 27, 1, p. 97-100 4 p.

Research output: Contribution to journalReview article

5 Scopus citations
2008

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Scher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., Petrylak, D., Kantoff, P., Basch, E., Kelly, W. K., Figg, W. D., Small, E. J., Beer, T. M., Wilding, G., Martin, A. & Hussain, M., Mar 1 2008, In : Journal of Clinical Oncology. 26, 7, p. 1148-1159 12 p.

Research output: Contribution to journalReview article

1496 Scopus citations
2007

American Society of Clinical Oncology endorsement of the Cancer Care Ontario practice Guideline on Nonhormonal Therapy for Men with Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer

Basch, E. M., Somerfield, M. R., Beer, T. M., Carducci, M. A., Higano, C. S., Hussain, M. H. A. & Scher, H. I., Nov 20 2007, In : Journal of Clinical Oncology. 25, 33, p. 5313-5318 6 p.

Research output: Contribution to journalReview article

76 Scopus citations
2006
19 Scopus citations

Calcitriol in the treatment of prostate cancer1

Beer, T. M. & Myrthue, A., Jul 1 2006, In : Anticancer research. 26, 4 A, p. 2647-2651 5 p.

Research output: Contribution to journalReview article

41 Scopus citations

Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer

Garzotto, M., Myrthue, A., Higano, C. S. & Beer, T. M., May 1 2006, In : Urologic Oncology: Seminars and Original Investigations. 24, 3, p. 254-259 6 p.

Research output: Contribution to journalReview article

28 Scopus citations

Parenteral estrogens for prostate cancer: Can a new route of administration overcome old toxicities?

Lycette, J. L., Bland, L. B., Garzotto, M. & Beer, T. M., Dec 2006, In : Clinical Genitourinary Cancer. 5, 3, p. 198-205 8 p.

Research output: Contribution to journalReview article

4 Scopus citations
2005

ASCENT: The androgen-independent prostate cancer study of calcitriol enhancing taxotere

Beer, T. M., Sep 1 2005, In : BJU international. 96, 4, p. 508-513 6 p.

Research output: Contribution to journalReview article

42 Scopus citations
2004

Prevention and management of prostate cancer chemotherapy complications

Beer, T. M. & Bubalo, J. S., May 1 2004, In : Urologic Clinics of North America. 31, 2, p. 367-378 12 p.

Research output: Contribution to journalReview article

6 Scopus citations
2003

Advanced penile carcinoma

Culkin, D. J. & Beer, T. M., Aug 1 2003, In : Journal of Urology. 170, 2 I, p. 359-365 7 p.

Research output: Contribution to journalReview article

120 Scopus citations
2002

Effects of docetaxel on pain due to metastatic androgen-independent prostate cancer.

Beer, T. M. & Bubalo, J. S., Jun 2002, In : Current urology reports. 3, 3, p. 232-238 7 p.

Research output: Contribution to journalReview article

5 Scopus citations
2001

Allogeneic stem-cell transplantation in renal-cell carcinoma.

Hayes-Lattin, B. M., Maziarz, R. T. & Beer, T. M., Sep 2001, In : Current oncology reports. 3, 5, p. 433-437 5 p.

Research output: Contribution to journalReview article

4 Scopus citations

Complications of chemotherapy for prostate cancer

Beer, T. M. & Bubalo, J. S., Sep 15 2001, In : Seminars in Urologic Oncology. 19, 3, p. 222-230 9 p.

Research output: Contribution to journalReview article

9 Scopus citations
2000

Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

Beer, T. & Raghavan, D., Oct 16 2000, In : Prostate. 45, 2, p. 184-193 10 p.

Research output: Contribution to journalReview article

26 Scopus citations